These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 21407180

  • 1. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
    Bernstein CN, Nugent Z, Blanchard JF.
    Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
    [Abstract] [Full Text] [Related]

  • 2. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?
    Bernstein CN, Blanchard JF, Metge C, Yogendran M.
    Am J Gastroenterol; 2003 Dec; 98(12):2784-8. PubMed ID: 14687833
    [Abstract] [Full Text] [Related]

  • 3. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH.
    Scand J Gastroenterol; 2009 Dec; 44(1):46-55. PubMed ID: 18609187
    [Abstract] [Full Text] [Related]

  • 4. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
    Mak JWY, So J, Tang W, Yip TCF, Leung WK, Li M, Lo FH, Ng KM, Sze SF, Leung CM, Tsang SWC, Shan EHS, Chan KH, Lam BCY, Hui AJ, Chow WH, Chan FKL, Ng SC.
    Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788
    [Abstract] [Full Text] [Related]

  • 5. 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study.
    van Staa TP, Card T, Logan RF, Leufkens HG.
    Gut; 2005 Nov; 54(11):1573-8. PubMed ID: 15994215
    [Abstract] [Full Text] [Related]

  • 6. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.
    Söderlund S, Granath F, Broström O, Karlén P, Löfberg R, Ekbom A, Askling J.
    Gastroenterology; 2010 May; 138(5):1697-703. PubMed ID: 20167217
    [Abstract] [Full Text] [Related]

  • 7. [Inflammatory bowel disease and colorectal cancer].
    Hagymási K, Tulassay Z.
    Orv Hetil; 2006 Oct 15; 147(41):1977-82. PubMed ID: 17120688
    [Abstract] [Full Text] [Related]

  • 8. Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease.
    van Schaik FD, van Oijen MG, Smeets HM, van der Heijden GJ, Siersema PD, Oldenburg B.
    Gut; 2012 Feb 15; 61(2):235-40. PubMed ID: 21602529
    [Abstract] [Full Text] [Related]

  • 9. 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease.
    Terdiman JP, Steinbuch M, Blumentals WA, Ullman TA, Rubin DT.
    Inflamm Bowel Dis; 2007 Apr 15; 13(4):367-71. PubMed ID: 17206695
    [Abstract] [Full Text] [Related]

  • 10. Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study.
    Metge CJ, Blanchard JF, Peterson S, Bernstein CN.
    Am J Gastroenterol; 2001 Dec 15; 96(12):3348-55. PubMed ID: 11774948
    [Abstract] [Full Text] [Related]

  • 11. Colorectal cancer prognosis among patients with inflammatory bowel disease.
    Delaunoit T, Limburg PJ, Goldberg RM, Lymp JF, Loftus EV.
    Clin Gastroenterol Hepatol; 2006 Mar 15; 4(3):335-42. PubMed ID: 16527697
    [Abstract] [Full Text] [Related]

  • 12. Drug insight: aminosalicylates for the treatment of IBD.
    Nielsen OH, Munck LK.
    Nat Clin Pract Gastroenterol Hepatol; 2007 Mar 15; 4(3):160-70. PubMed ID: 17339853
    [Abstract] [Full Text] [Related]

  • 13. Chemoprevention for colon cancer: new opportunities, fact or fiction?
    Terhaar Sive Droste JS, Tuynman JB, Van Dullemen HM, Mulder CJ.
    Scand J Gastroenterol Suppl; 2006 Mar 15; (243):158-64. PubMed ID: 16782636
    [Abstract] [Full Text] [Related]

  • 14. Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis.
    Shaw SY, Blanchard JF, Bernstein CN.
    Am J Gastroenterol; 2011 Dec 15; 106(12):2133-42. PubMed ID: 21912437
    [Abstract] [Full Text] [Related]

  • 15. The association between corticosteroid use and development of fractures among IBD patients in a population-based database.
    Bernstein CN, Blanchard JF, Metge C, Yogendran M.
    Am J Gastroenterol; 2003 Aug 15; 98(8):1797-801. PubMed ID: 12907335
    [Abstract] [Full Text] [Related]

  • 16. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
    Lakatos L, Mester G, Erdélyi Z, David G, Pandúr T, Balogh M, Fischer S, Vargha P, Lakatos PL.
    Orv Hetil; 2006 Jan 29; 147(4):175-81. PubMed ID: 16515026
    [Abstract] [Full Text] [Related]

  • 17. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN, Wajda A, Blanchard JF.
    Clin Gastroenterol Hepatol; 2008 Jan 29; 6(1):41-5. PubMed ID: 18063423
    [Abstract] [Full Text] [Related]

  • 18. [Colorectal cancer in inflammatory bowel disease].
    Henriksen M, Moum B.
    Tidsskr Nor Laegeforen; 2007 Oct 18; 127(20):2696-9. PubMed ID: 17952155
    [Abstract] [Full Text] [Related]

  • 19. Risk factors of colorectal cancer in inflammatory bowel disease.
    Bansal P, Sonnenberg A.
    Am J Gastroenterol; 1996 Jan 18; 91(1):44-8. PubMed ID: 8561142
    [Abstract] [Full Text] [Related]

  • 20. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.
    Qiu X, Ma J, Wang K, Zhang H.
    Oncotarget; 2017 Jan 03; 8(1):1031-1045. PubMed ID: 27906680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.